Influence of carvedilol (Dilatrend) on physical fitness and quality of life: assessment by accelerometry (using Physilog) in patients with heart failure (CALL study)
Phase of Trial: Phase IV
Latest Information Update: 23 Feb 2010
At a glance
- Drugs Carvedilol (Primary)
- Indications Heart failure
- Focus Therapeutic Use
- Acronyms CALL
- Sponsors Roche
- 15 Feb 2008 Status changed from in progress to completed; according to Roche.
- 02 Jun 2006 New trial record.